Resource utilization and costs associated with the addition of an antimuscarinic in patients treated with an alpha-blocker for the treatment of urinary symptoms linked to benign prostatic hyperplasia

BACKGROUND: There has been a change in the focus of attention from prostate to bladder, as the etiology of lower urinary tract symptoms (LUTS) makes the bladder an additional therapeutic target. This study aims to evaluate the use of resources and costs associated with the addition of an antimuscari...

Descripción completa

Detalles Bibliográficos
Autores principales: Sicras-Mainar, Antoni, Navarro-Artieda, Ruth, Mora, Ana Mª., Hernández, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596857/
https://www.ncbi.nlm.nih.gov/pubmed/28899370
http://dx.doi.org/10.1186/s12894-017-0275-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596857/
https://www.ncbi.nlm.nih.gov/pubmed/28899370
http://dx.doi.org/10.1186/s12894-017-0275-6

Ejemplares similares